These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38260620)

  • 1. Identification of Novel Biomarkers for Alzheimer's Disease and Related Dementias Using Unbiased Plasma Proteomics.
    Lacar B; Ferdosi S; Alavi A; Stukalov A; Venkataraman GR; de Geus M; Dodge H; Wu CY; Kivisakk P; Das S; Guturu H; Hyman B; Batzoglou S; Arnold SE; Siddiqui A
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
    Ferreira PCL; Zhang Y; Snitz B; Chang CH; Bellaver B; Jacobsen E; Kamboh MI; Zetterberg H; Blennow K; Pascoal TA; Villemagne VL; Ganguli M; Karikari TK
    Alzheimers Dement; 2023 Oct; 19(10):4507-4519. PubMed ID: 36876954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. timsTOF HT Improves Protein Identification and Quantitative Reproducibility for Deep Unbiased Plasma Protein Biomarker Discovery.
    Vitko D; Chou WF; Nouri Golmaei S; Lee JY; Belthangady C; Blume J; Chan JK; Flores-Campuzano G; Hu Y; Liu M; Marispini MA; Mora MG; Ramaswamy S; Ranjan P; Williams PB; Zawada RJX; Ma P; Wilcox BE
    J Proteome Res; 2024 Mar; 23(3):929-938. PubMed ID: 38225219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease-Related Dementias Summit 2022: National Research Priorities for the Investigation of Post-Traumatic Brain Injury Alzheimer's Disease and Related Dementias.
    Dams-O'Connor K; Awwad HO; Hoffman S; Pugh MJ; Johnson VE; Keene CD; McGavern L; Mukherjee P; Opanashuk L; Umoh N; Sopko G; Zetterberg H
    J Neurotrauma; 2023 Aug; 40(15-16):1512-1523. PubMed ID: 36927167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.
    Inoue M; Suzuki H; Meno K; Liu S; Korenaga T; Uchida K
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
    Perrin RJ; Craig-Schapiro R; Malone JP; Shah AR; Gilmore P; Davis AE; Roe CM; Peskind ER; Li G; Galasko DR; Clark CM; Quinn JF; Kaye JA; Morris JC; Holtzman DM; Townsend RR; Fagan AM
    PLoS One; 2011 Jan; 6(1):e16032. PubMed ID: 21264269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.
    Hadjidemetriou M; Rivers-Auty J; Papafilippou L; Eales J; Kellett KAB; Hooper NM; Lawrence CB; Kostarelos K
    ACS Nano; 2021 Apr; 15(4):7357-7369. PubMed ID: 33730479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.
    Tsiknia AA; Edland SD; Sundermann EE; Reas ET; Brewer JB; Galasko D; Banks SJ;
    Mol Psychiatry; 2022 Oct; 27(10):4314-4322. PubMed ID: 35768637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer's disease.
    Dey KK; Wang H; Niu M; Bai B; Wang X; Li Y; Cho JH; Tan H; Mishra A; High AA; Chen PC; Wu Z; Beach TG; Peng J
    Clin Proteomics; 2019; 16():16. PubMed ID: 31019427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
    Groot C; Cicognola C; Bali D; Triana-Baltzer G; Dage JL; Pontecorvo MJ; Kolb HC; Ossenkoppele R; Janelidze S; Hansson O
    Alzheimers Res Ther; 2022 May; 14(1):67. PubMed ID: 35568889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
    Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
    JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people.
    Rabl M; Clark C; Dayon L; Bowman GL; Popp J
    J Neurochem; 2023 Jan; 164(2):242-254. PubMed ID: 36281546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
    Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
    Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O
    Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning.
    Kononikhin AS; Zakharova NV; Semenov SD; Bugrova AE; Brzhozovskiy AG; Indeykina MI; Fedorova YB; Kolykhalov IV; Strelnikova PA; Ikonnikova AY; Gryadunov DA; Gavrilova SI; Nikolaev EN
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
    Bader JM; Geyer PE; Müller JB; Strauss MT; Koch M; Leypoldt F; Koertvelyessy P; Bittner D; Schipke CG; Incesoy EI; Peters O; Deigendesch N; Simons M; Jensen MK; Zetterberg H; Mann M
    Mol Syst Biol; 2020 Jun; 16(6):e9356. PubMed ID: 32485097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.